Cargando…
Is the thymidine labeling index a good prognostic marker in breast cancer?
BACKGROUND: The aim of the present study was to determine the prognostic relevance of thymidine labeling index (TLI) in patients with breast cancer. METHODS: TLI of the primary tumor was measured in 268 patients at the time of the surgical biopsy by an in vitro method. RESULTS: Fifty-four patients h...
Autores principales: | Sen-Oran, Ebru, Ozmen, Vahit, Bilir, Ayhan, Cabioglu, Neslihan, Muslumanoglu, Mahmut, Igci, Abdullah, Guney, Nese, Kecer, Mustafa |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2007
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2000894/ https://www.ncbi.nlm.nih.gov/pubmed/17705874 http://dx.doi.org/10.1186/1477-7819-5-93 |
Ejemplares similares
-
Breast cancer risk factors in Turkish women – a University Hospital based nested case control study
por: Ozmen, Vahit, et al.
Publicado: (2009) -
Is Breast Conserving Surgery Efficacious in Breast Cancer Patients with BRCA1 or BRCA2 Germline Mutation?
por: Emiroglu, Selman, et al.
Publicado: (2023) -
Favorable Outcome with Close Margins in Patients Undergoing Nipple/Skin Sparing Mastectomy with Immediate Breast Reconstruction: 5-year Follow-up
por: Özkurt, Enver, et al.
Publicado: (2018) -
High co-expression of immune checkpoint receptors PD-1, CTLA-4, LAG-3, TIM-3, and TIGIT on tumor-infiltrating lymphocytes in early-stage breast cancer
por: Mollavelioglu, Baran, et al.
Publicado: (2022) -
TIM3 expression on TILs is associated with poor response to neoadjuvant chemotherapy in patients with locally advanced triple-negative breast cancer
por: Cabioglu, Neslihan, et al.
Publicado: (2021)